Showing posts with label Generic Drugs. Show all posts
Showing posts with label Generic Drugs. Show all posts

Friday, 14 December 2018

Generic Injectables Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Researchmoz added Most up-to-date research on "Generic Injectables Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025" to its huge collection of research reports. An insight on the important factors and trends influencing the market.

Generic Injectables Market – Overview

This comprehensive report by Transparency Market Research analyzes the global generic injectables market for the period between 2017 and 2025. An in-depth and unbiased market assessment has been made, which offers an in-depth and accurate analysis. Market projections have been offered in terms of value (US$ Mn). Stakeholders of this report include companies and intermediaries engaged in manufacturing and distribution of generic injectable products as well as new entrants planning to enter this market.

The global generic injectables market has been studied for the forecast period of 2017 to 2025. For research, 2016 has been considered as the base year and 2015 as the historical year, while all forecasts have been provided from 2017 to 2025. The global generic injectables market report comprises an elaborate executive summary that provides overall information about various segments of the market. The report provides a detailed competitive landscape, by major players operating in this market along with their shares (value %) of the global generic injectables market for 2016. The report also provides detail company profiles of emerging market players operating in the global generic injectables market.

Get a Sample PDF at: https://www.researchmoz.us/enquiry.php?type=S&repid=1769904

The market overview section comprises factors such as key market dynamics including drivers, restraints, and opportunities affecting the demand for generic injectable products in the global market. These factors are likely to aid stakeholders establish a strong foothold in the global generic injectables market. Furthermore, the market overview section comprises key industry events, product overview, and market attractiveness analysis in the global generic injectables market. The market attractiveness analysis provides a graphical view comparing the expansion and market dynamics in various segments and countries to identify the most attractive market.

Generic Injectables Market - Scope

The global generic injectables market has been segmented based on product type, container type applications, and route of administration. In terms of product type, the global generic injectables market has been bifurcated into large molecule injectables, also known as generic biologics or biosimilar products, and small molecule injectables. The large molecule injectables segment has been further sub-segmented into monoclonal antibodies {monoclonal antibodies (mAbs)}, insulin, and others. Based on container type, the global generic injectables market has been categorized into vials, ampoules, premixes, prefilled syringes, and others. In terms of application, the global generic injectables market has been categorized into oncology, infectious diseases, cardiology, diabetes, immunology, and others. Based on route of administration, the global generic injectables market has been categorized into intravenous, intramuscular, subcutaneous, and others.

In terms of geography, the global generic injectables market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Moreover, analysis for major countries comprising the U.S., Canada, Germany, France, the U.K., Italy, Spain, Russia, China, Japan, India, Australia & New Zealand, Brazil, Mexico, South Africa, Israel, and GCC Countries has also been provided in the report. A detailed qualitative analysis of the factors responsible for driving and restraining the generic injectables market in various regions has been provided in this section.

The report renders a detailed outline/blueprint of the generic injectables market globally that is expected to assist new companies establish their presence and market players expand their share in the market. The report concludes with the company profile section, which includes company overview, financial overview, SWOT analysis, product portfolio, business strategies, and recent developments.

Get Complete TOC With Tables and Figures @ https://www.researchmoz.us/generic-injectables-market-global-industry-analysis-size-share-growth-trends-and-forecast-2017-2025-report.html/toc

Competitive landscape

Major players operating in the global generic injectables market include Pfizer Inc., Novartis AG (Sandoz International GmbH), Baxter, Fresenius SE & Co. KGaA, Mylan N.V., Teva Pharmaceutical Industries Ltd., Hikma Pharmaceuticals PLC., Lupin Ltd., and Sanofi, Biocon. Other prominent players operating in the global generic injectables market include Dr. Reddy’s Laboratories, Aurobindo Pharma, Sagent Pharmaceuticals Inc., Zydus Cadila, GlaxoSmithKline plc, and AstraZeneca plc.

The global generic injectables market has been segmented into:

Global Generic Injectables Market, by Product Type,
- Large Molecule Injectables (Biosimilars)
- Small Molecule Injectables

Global Generic Injectables Market, by Container Type,
- Vials
- Ampoules
- Premixes
- Prefilled Syringes
- Others

Global Generic Injectables Market, by Application
- Oncology
- Infectious Diseases
- Cardiology
- Diabetes
- Immunology
- Others

Global Generic Injectables Market, by Route of Administration
- Intravenous
- Intramuscular
- Subcutaneous
- Others

Make an Enquiry of this report @ https://www.researchmoz.us/enquiry.php?type=E&repid=1769904

Global Generic Injectables Market, by Geography

North America
- U.S.
- Canada

Europe
- Germany
- France
- Italy
- U.K.
- Russia
- Spain
- Rest of Europe

Asia Pacific
- China
- India
- Japan
- Australia & New Zealand
- Rest of Asia Pacific

Latin America
- Brazil
- Mexico
- Rest of Latin America

Middle East & Africa
- GCC Countries
- South Africa
- Israel
- Rest of Middle East & Africa

About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfil all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organisations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us

For More Reports Visit @ http://marketresearchlatestreports.blogspot.com/

Thursday, 29 November 2018

Generic Injectables Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025 | Now Available at Researchmoz.us

Researchmoz added Most up-to-date research on "Generic Injectables Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025" to its huge collection of research reports. An insight on the important factors and trends influencing the market.

Generic Injectables Market – Overview

This comprehensive report by Transparency Market Research analyzes the global generic injectables market for the period between 2017 and 2025. An in-depth and unbiased market assessment has been made, which offers an in-depth and accurate analysis. Market projections have been offered in terms of value (US$ Mn). Stakeholders of this report include companies and intermediaries engaged in manufacturing and distribution of generic injectable products as well as new entrants planning to enter this market.

Get a Sample PDF at: https://www.researchmoz.us/enquiry.php?type=S&repid=1769904

The global generic injectables market has been studied for the forecast period of 2017 to 2025. For research, 2016 has been considered as the base year and 2015 as the historical year, while all forecasts have been provided from 2017 to 2025. The global generic injectables market report comprises an elaborate executive summary that provides overall information about various segments of the market. The report provides a detailed competitive landscape, by major players operating in this market along with their shares (value %) of the global generic injectables market for 2016. The report also provides detail company profiles of emerging market players operating in the global generic injectables market.

The market overview section comprises factors such as key market dynamics including drivers, restraints, and opportunities affecting the demand for generic injectable products in the global market. These factors are likely to aid stakeholders establish a strong foothold in the global generic injectables market. Furthermore, the market overview section comprises key industry events, product overview, and market attractiveness analysis in the global generic injectables market. The market attractiveness analysis provides a graphical view comparing the expansion and market dynamics in various segments and countries to identify the most attractive market.

Generic Injectables Market - Scope

The global generic injectables market has been segmented based on product type, container type applications, and route of administration. In terms of product type, the global generic injectables market has been bifurcated into large molecule injectables, also known as generic biologics or biosimilar products, and small molecule injectables. The large molecule injectables segment has been further sub-segmented into monoclonal antibodies {monoclonal antibodies (mAbs)}, insulin, and others. Based on container type, the global generic injectables market has been categorized into vials, ampoules, premixes, prefilled syringes, and others. In terms of application, the global generic injectables market has been categorized into oncology, infectious diseases, cardiology, diabetes, immunology, and others. Based on route of administration, the global generic injectables market has been categorized into intravenous, intramuscular, subcutaneous, and others.

Get Complete TOC With Tables and Figures @ https://www.researchmoz.us/generic-injectables-market-global-industry-analysis-size-share-growth-trends-and-forecast-2017-2025-report.html/toc

In terms of geography, the global generic injectables market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Moreover, analysis for major countries comprising the U.S., Canada, Germany, France, the U.K., Italy, Spain, Russia, China, Japan, India, Australia & New Zealand, Brazil, Mexico, South Africa, Israel, and GCC Countries has also been provided in the report. A detailed qualitative analysis of the factors responsible for driving and restraining the generic injectables market in various regions has been provided in this section.

The report renders a detailed outline/blueprint of the generic injectables market globally that is expected to assist new companies establish their presence and market players expand their share in the market. The report concludes with the company profile section, which includes company overview, financial overview, SWOT analysis, product portfolio, business strategies, and recent developments.

Competitive landscape

Major players operating in the global generic injectables market include Pfizer Inc., Novartis AG (Sandoz International GmbH), Baxter, Fresenius SE & Co. KGaA, Mylan N.V., Teva Pharmaceutical Industries Ltd., Hikma Pharmaceuticals PLC., Lupin Ltd., and Sanofi, Biocon. Other prominent players operating in the global generic injectables market include Dr. Reddy’s Laboratories, Aurobindo Pharma, Sagent Pharmaceuticals Inc., Zydus Cadila, GlaxoSmithKline plc, and AstraZeneca plc.

The global generic injectables market has been segmented into:

Global Generic Injectables Market, by Product Type,
- Large Molecule Injectables (Biosimilars)
- Small Molecule Injectables

Global Generic Injectables Market, by Container Type,
- Vials
- Ampoules
- Premixes
- Prefilled Syringes
- Others

Global Generic Injectables Market, by Application
- Oncology
- Infectious Diseases
- Cardiology
- Diabetes
- Immunology
- Others

Global Generic Injectables Market, by Route of Administration
- Intravenous
- Intramuscular
- Subcutaneous
- Others

Make an Enquiry of this report @ https://www.researchmoz.us/enquiry.php?type=E&repid=1769904

Global Generic Injectables Market, by Geography

North America
- U.S.
- Canada

Europe
- Germany
- France
- Italy
- U.K.
- Russia
- Spain
- Rest of Europe

Asia Pacific
- China
- India
- Japan
- Australia & New Zealand
- Rest of Asia Pacific

Latin America
- Brazil
- Mexico
- Rest of Latin America

Middle East & Africa
- GCC Countries
- South Africa
- Israel
- Rest of Middle East & Africa

About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfil all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organisations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us

For More Reports Visit @ http://marketresearchlatestreports.blogspot.com/

Wednesday, 7 June 2017

New Study Reveals Future of Generic Drugs and Strategies for Commercial Success | Researchmoz

Researchmoz added Most up-to-date research on "The Future of Generic Drugs and Strategies for Commercial Success" to its huge collection of research reports.

Latest report “The Future of Generic Drugs and Strategies for Commercial Success” discusses trends in the global generic drugs market, and the evolving business strategies being adopted and leveraged by generic drug companies around the world. GBI Research conducted an extensive and targeted industry survey of experts from top global generic drug companies, to gather opinions on the trends and future commercial prospects of the generic drugs market. The findings from the survey and results from extensive data analysis and secondary research efforts have been triangulated with GBI’s own analytical views to provide an objective assessment that is comprehensive in outlook.

The generic drugs market has seen rapid expansion for more than 30 years, and consistently achieves higher annual growth rates than the overall pharmaceutical market. The increase in generic drug activity can be primarily attributed to the promise of significant revenues from blockbuster drugs nearing patent expiry. In the US – the largest generic drugs market by revenue – the number of generic drug approvals hit a record high in 2015, due to a new program that aimed to speed up approvals. There has also recently been a surge in the number of industry-transforming mergers and acquisitions, with companies looking to consolidate their position in this highly lucrative market.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=848086

The results of GBI’s latest industry survey provide insightful analyses from different expert panels, including R&D and commercial, and highlight trends observed in key geographical markets. The survey examined key commercial issues and recent developments in the generic drugs market, such as the reasons behind the surge in mergers and acquisitions, and the likely effects on market dynamics. It covered important factors currently driving or restraining the market, prospects for key therapy areas expected to exhibit significant levels of genericization in the coming years, and the most promising emerging markets for generic companies in terms of revenue potential. Additionally, the survey examined common business strategies and regulations being leveraged by global generic drug companies for market expansion.

The report covers key small molecule drugs whose patents will expire in the coming years, providing an in-depth assessment of potential generic competition, expected launch dates and the overall impact on global branded revenues to 2021. The top global generic drug companies by revenue are also examined, including financial performance and recent activity within the market.

This new report adds to our unique portfolio of trusted industry analyses, which enable our clients to assess the most promising commercial areas in the market and identify key business opportunities.

Scope

- What is the current value of the generic drugs market, and how will market dynamics change in the coming years?
- Will the US continue to dominate the market?
- Which therapy areas will witness the highest level of genericization in the next five years?

Drivers and restraints in the generics industry:

- What are the most important factors promoting generic drug usage at a global level?
- What are the most important factors hindering or delaying generic drug approvals?
- Will governments worldwide continue their efforts to promote generic drug usage?
- How will global demographic trends impact demand for generic drugs?
- Which emerging economies are the most promising for generic drugs companies?
- Are generic drugs still negatively perceived?
- How are pricing pressures and rising costs affecting generic drug manufacturers?
- Generic drugs pipeline for top small molecule drugs in the market:
- What will be the revenue impact for key small molecule drugs whose patents expire in the near future?
- What are the key patent expiry dates for these small molecules and what level of generic competition should they expect?
- Strategies for commercial success:
- What are the most popular strategies or regulations being adopted and leveraged by generic drug manufacturers?
- What governmental policies are significantly influencing generic drug usage?
- What will be the impact of compulsory licenses in emerging markets?
- Mergers and acquisitions in the global generic drugs market:
- What are the most important factors contributing to the surge in M&A activity in the generic drugs market?
- How will market dynamics be affected by continued consolidation in the generic drugs market?
- What have been the most important transactions in the generic drugs industry in recent years?
- Top global generic drugs companies:
- How have top generic drugs companies performed in recent years?
- What are the prospects for top generic drugs companies?

Reasons to buy

This report will allow you to

- Gain insightful analyses and understanding of market dynamics: This report comprehensively describes and assesses the most important factors driving and restraining the generic drugs market. It assesses pertinent commercial and regulatory aspects of the industry by combining survey results with proprietary in-house expertise and extensive secondary research efforts.
- Assess the generic drugs pipeline for top small molecule drugs in the market: Our study provides prospects for these drugs beyond their patent expiries, including potential generic competition, expected launch dates and revenue forecasts to 2021.
- Evaluate the strategies used by companies to promote generic drug usage: This report provides insights regarding the various commercial strategies being adopted and leveraged by generic drug companies to promote their therapies.
- Understand government policies and strategies to promote generic drug usage: This report assesses current strategies and regulations implemented by governments in key geographic markets to promote generic drug usage.
- Gain insight on mergers and acquisitions in the global generic drugs market: This report describes industry-transforming mergers and acquisitions that have occurred in recent years, the reasons behind the recent surge in these types of transactions, and their likely impact on market dynamics.

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=848086

Friday, 2 June 2017

Professional Survey Report on Global Generic Drugs Market Analysis 2017

Researchmoz added Most up-to-date research on "Global Generic Drugs Market Professional Survey Report 2017" to its huge collection of research reports.

This report studies Generic Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Teva Pharma.
Novartis company
Mylan
Allergan
Hospira
Dr. Reddys Lab.
Stada
Greenstone
Par Pharma
Sun Pharmaceutical
Aspen Pharmacare
Fresenius
Lupin

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=923502

By types, the market can be split into
Pure (Non-branded) Generics
Branded Generics
Super Generics

By Application, the market can be split into
Cardiovascular & Hypertension
Dermatology
Diabetes
Rheumatology
Oncology
Gastrointestinal
Others

By Regions, this report covers (we can add the regions/countries as you want)
North America
China
Europe
Southeast Asia
Japan
India

Table of Contents

Global Generic Drugs Market Professional Survey Report 2017
1 Industry Overview of Generic Drugs
1.1 Definition and Specifications of Generic Drugs
1.1.1 Definition of Generic Drugs
1.1.2 Specifications of Generic Drugs
1.2 Classification of Generic Drugs
1.2.1 Pure (Non-branded) Generics
1.2.2 Branded Generics
1.2.3 Super Generics
1.3 Applications of Generic Drugs
1.3.1 Cardiovascular & Hypertension
1.3.2 Dermatology
1.3.3 Diabetes
1.3.4 Rheumatology
1.3.5 Oncology
1.3.6 Gastrointestinal
1.3.7 Others
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India

2 Manufacturing Cost Structure Analysis of Generic Drugs
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Generic Drugs
2.3 Manufacturing Process Analysis of Generic Drugs
2.4 Industry Chain Structure of Generic Drugs

3 Technical Data and Manufacturing Plants Analysis of Generic Drugs
3.1 Capacity and Commercial Production Date of Global Generic Drugs Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Generic Drugs Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Generic Drugs Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Generic Drugs Major Manufacturers in 2015

4 Global Generic Drugs Overall Market Overview
4.1 2011-2016 Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2011-2016 Global Generic Drugs Capacity and Growth Rate Analysis
4.2.2 2015 Generic Drugs Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2011-2016 Global Generic Drugs Sales and Growth Rate Analysis
4.3.2 2015 Generic Drugs Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2011-2016 Global Generic Drugs Sales Price
4.4.2 2015 Generic Drugs Sales Price Analysis (Company Segment)

5 Generic Drugs Regional Market Analysis
5.1 North America Generic Drugs Market Analysis
5.1.1 North America Generic Drugs Market Overview
5.1.2 North America 2011-2016 Generic Drugs Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2011-2016 Generic Drugs Sales Price Analysis
5.1.4 North America 2015 Generic Drugs Market Share Analysis
5.2 China Generic Drugs Market Analysis
5.2.1 China Generic Drugs Market Overview
5.2.2 China 2011-2016 Generic Drugs Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2011-2016 Generic Drugs Sales Price Analysis
5.2.4 China 2015 Generic Drugs Market Share Analysis
5.3 Europe Generic Drugs Market Analysis
5.3.1 Europe Generic Drugs Market Overview
5.3.2 Europe 2011-2016 Generic Drugs Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2011-2016 Generic Drugs Sales Price Analysis
5.3.4 Europe 2015 Generic Drugs Market Share Analysis
5.4 Southeast Asia Generic Drugs Market Analysis
5.4.1 Southeast Asia Generic Drugs Market Overview
5.4.2 Southeast Asia 2011-2016 Generic Drugs Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Southeast Asia 2011-2016 Generic Drugs Sales Price Analysis
5.4.4 Southeast Asia 2015 Generic Drugs Market Share Analysis
5.5 Japan Generic Drugs Market Analysis
5.5.1 Japan Generic Drugs Market Overview
5.5.2 Japan 2011-2016 Generic Drugs Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Japan 2011-2016 Generic Drugs Sales Price Analysis
5.5.4 Japan 2015 Generic Drugs Market Share Analysis
5.6 India Generic Drugs Market Analysis
5.6.1 India Generic Drugs Market Overview
5.6.2 India 2011-2016 Generic Drugs Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2011-2016 Generic Drugs Sales Price Analysis
5.6.4 India 2015 Generic Drugs Market Share Analysis

6 Global 2011-2016 Generic Drugs Segment Market Analysis (by Type)
6.1 Global 2011-2016 Generic Drugs Sales by Type
6.2 Different Types of Generic Drugs Product Interview Price Analysis
6.3 Different Types of Generic Drugs Product Driving Factors Analysis
6.3.1 Pure (Non-branded) Generics of Generic Drugs Growth Driving Factor Analysis
6.3.2 Branded Generics of Generic Drugs Growth Driving Factor Analysis
6.3.3 Super Generics of Generic Drugs Growth Driving Factor Analysis

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=923502

Wednesday, 12 April 2017

New Survey Reveals The Future of Generic Drugs and Strategies for Commercial Success

Researchmoz added Most up-to-date research on "The Future of Generic Drugs and Strategies for Commercial Success" to its huge collection of research reports.

GBI Research’s latest report “The Future of Generic Drugs and Strategies for Commercial Success” discusses trends in the global generic drugs market, and the evolving business strategies being adopted and leveraged by generic drug companies around the world. GBI Research conducted an extensive and targeted industry survey of experts from top global generic drug companies, to gather opinions on the trends and future commercial prospects of the generic drugs market. The findings from the survey and results from extensive data analysis and secondary research efforts have been triangulated with GBI’s own analytical views to provide an objective assessment that is comprehensive in outlook.

The generic drugs market has seen rapid expansion for more than 30 years, and consistently achieves higher annual growth rates than the overall pharmaceutical market. The increase in generic drug activity can be primarily attributed to the promise of significant revenues from blockbuster drugs nearing patent expiry. In the US – the largest generic drugs market by revenue – the number of generic drug approvals hit a record high in 2015, due to a new program that aimed to speed up approvals. There has also recently been a surge in the number of industry-transforming mergers and acquisitions, with companies looking to consolidate their position in this highly lucrative market.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=848086

The results of GBI’s latest industry survey provide insightful analyses from different expert panels, including R&D and commercial, and highlight trends observed in key geographical markets. The survey examined key commercial issues and recent developments in the generic drugs market, such as the reasons behind the surge in mergers and acquisitions, and the likely effects on market dynamics. It covered important factors currently driving or restraining the market, prospects for key therapy areas expected to exhibit significant levels of genericization in the coming years, and the most promising emerging markets for generic companies in terms of revenue potential. Additionally, the survey examined common business strategies and regulations being leveraged by global generic drug companies for market expansion.

The report covers key small molecule drugs whose patents will expire in the coming years, providing an in-depth assessment of potential generic competition, expected launch dates and the overall impact on global branded revenues to 2021. The top global generic drug companies by revenue are also examined, including financial performance and recent activity within the market.

This new report adds to our unique portfolio of trusted industry analyses, which enable our clients to assess the most promising commercial areas in the market and identify key business opportunities.

Scope

- What is the current value of the generic drugs market, and how will market dynamics change in the coming years?
- Will the US continue to dominate the market?
- Which therapy areas will witness the highest level of genericization in the next five years?

Drivers and restraints in the generics industry:

- What are the most important factors promoting generic drug usage at a global level?
- What are the most important factors hindering or delaying generic drug approvals?
- Will governments worldwide continue their efforts to promote generic drug usage?
- How will global demographic trends impact demand for generic drugs?
- Which emerging economies are the most promising for generic drugs companies?
- Are generic drugs still negatively perceived?
- How are pricing pressures and rising costs affecting generic drug manufacturers?
- Generic drugs pipeline for top small molecule drugs in the market:
- What will be the revenue impact for key small molecule drugs whose patents expire in the near future?
- What are the key patent expiry dates for these small molecules and what level of generic competition should they expect?
- Strategies for commercial success:
- What are the most popular strategies or regulations being adopted and leveraged by generic drug manufacturers?
- What governmental policies are significantly influencing generic drug usage?
- What will be the impact of compulsory licenses in emerging markets?
- Mergers and acquisitions in the global generic drugs market:
- What are the most important factors contributing to the surge in M&A activity in the generic drugs market?
- How will market dynamics be affected by continued consolidation in the generic drugs market?
- What have been the most important transactions in the generic drugs industry in recent years?
- Top global generic drugs companies:
- How have top generic drugs companies performed in recent years?
- What are the prospects for top generic drugs companies?

Reasons to buy

This report will allow you to

- Gain insightful analyses and understanding of market dynamics: This report comprehensively describes and assesses the most important factors driving and restraining the generic drugs market. It assesses pertinent commercial and regulatory aspects of the industry by combining survey results with proprietary in-house expertise and extensive secondary research efforts.
- Assess the generic drugs pipeline for top small molecule drugs in the market: Our study provides prospects for these drugs beyond their patent expiries, including potential generic competition, expected launch dates and revenue forecasts to 2021.
- Evaluate the strategies used by companies to promote generic drug usage: This report provides insights regarding the various commercial strategies being adopted and leveraged by generic drug companies to promote their therapies.
- Understand government policies and strategies to promote generic drug usage: This report assesses current strategies and regulations implemented by governments in key geographic markets to promote generic drug usage.
- Gain insight on mergers and acquisitions in the global generic drugs market: This report describes industry-transforming mergers and acquisitions that have occurred in recent years, the reasons behind the recent surge in these types of transactions, and their likely impact on market dynamics.

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=848086

Thursday, 1 December 2016

Drug Recalls and Warning Letters - Increasing Numbers Caused by Manufacturing Errors and Regulatory Non-compliance Issues | Researchmoz.us

Researchmoz added Most up-to-date research on "Drug Recalls and Warning Letters - Increasing Numbers Caused by Manufacturing Errors and Regulatory Non-compliance Issues" to its huge collection of research reports.

GBI Researchs report, Drug Recalls and Warning Letters - Increasing Numbers Caused by Manufacturing Errors and Regulatory Non-compliance Issues, provides in-depth analysis of Warning Letters, drug recalls issued or reported with the US Food and Drug Administration (FDA) and its constituent agencies. The report analyzes warning letters from the issuing agencies and reason for these warning letters. The report contains year by year detailed analysis about warning letters issued for various reasons by regulatory authorities. The report is built on data and information sourced from the FDA database of warning letters and drug recalls and in-house analysis by GBI Researchs team of industry experts.

GBI Research indicates that the warning letters and drug recalls have significantly increased during 2007-2010, due to various underlying causes which are explained in detail in the report. The report also provides analysis of warning letters individually issued by the Center for Drug Evaluation (CDER), the Center for Biologics Evaluation and Research (CBER), the Center for Devices and Radiological Health (CDRH), the Center for Food Safety and Applied Nutrition (CFSAN), and the Center for Veterinary Medicine (CVM).

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=3341

The increase in the number of warning letters can be attributed to manufacturing defects present in recalled products. In the report, detailed analysis of recalled products, with the year of recall, recalling firm, dosage form, therapy area, reason for recall and the subset reason for recalls, is provided.

The report presents the year by year drug recall analysis by the recalling firms along with the reason for recall. In the analysis Class I drug recalls have been specially covered, while analysis for other types of recall have also been made. The report analyzes the percentage distribution of drug recalls in terms of dosage form, therapy area and other areas.

Scope

- The data and numerical figures on the number of warning letters and drug recalls issued according to the year of recall, recalling firm, and reporting FDA agency for 2007-2010.
- Analysis of leading therapeutic areas and dosage forms for major drug recalls were issued
- Analysis of reasons for recall, along with in-depth analysis of underlying reasons and showing its pattern from 2007-2010.
- In this report the warning letters and drug recalls were analyzed by drug class of the recalled drug products.

Reasons to buy

- Understand the pattern of warning letters and drug recalls, along with their underlying causes, so as to enable you to undertake various strategies in order to protect products from encountering safety issues.
- To analyze the major reasons for recall, along with the therapy areas and class of recalled drugs most vulnerable, so as to strengthen the areas which may lead to quality defects in your companys products.
- Reinforce quality and manufacturing strategies so as to be complaint with the current regulatory norms.
- Develop key strategic initiatives by understanding the key focus areas of the warning letters and drug recalls.

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=3341

Blood Thawing System Market Insights Shared in Detailed Report

Blood Thawing System Market: Introduction According to the report, the global  blood thawing system market  was valued at ~US$ 174 Mn in 2...